Trial Condition(s):
Dermatitis, Atopic
Efficacy and tolerance of once-daily methylprednisolone aceponate ointment in comparison with twice-daily hydrocortisone 17-butyrate in patients with atopic dermatitis
Bayer Identifier:
Trial_89172
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
213
Trial Dates
Phase
3
Could I receive a placebo?
No
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
Status
| Locations | Status |
|---|
For details, please refer to trial results
Additional Information
Not Available
Copyright © Bayer
Powered by
